Williams, Meininger tasked with validating Sana’s platforms in the clinic

As Sana heads into the clinic, it’s bringing on two new modality veterans to make the transition. The first order of business for Doug Williams and Gary Meininger will be rapid technology de-risking. 

On Monday, Sana Biotechnology Inc. (NASDAQ:SANA) announced that Doug Williams will step into the new president of R&D role, and that Gary Meininger will become the new CMO. Meininger replaces Sunil Agarwal, who will leave the company during the management transition. ...